M. Yaono et al., Lobe specific effects of testosterone and estrogen on 3,2 '-dimethyl-4-aminobiphenyl-induced rat prostate carcinogenesis, CANCER LETT, 150(1), 2000, pp. 33-40
We have previously shown that chronic administration of a pharmacological d
ose of testosterone propionate (TP) after treatment with the carcinogen, 3,
2'-dimethyl-4-aminobiphenyl (DMAB), results in development of invasive and
metastatic adenocarcinomas arising from the dorso-lateral and anterior pros
tate, as well as the seminal vesicles. Co-administration of ethinyl estradi
ol (EE) with TP increased the yield of carcinomas in the lateral and anteri
or lobes. In the present experiment, male F344 rats were treated with DMAB
for 20 weeks and then co-administered a pharmacological dose of TP together
with various doses of EE for 40 weeks. Without hormone(s) administration,
carcinomas were confined to the ventral prostate and all were of intra-acin
ar type. TP administration suppressed development of the ventral prostate c
arcinomas but caused invasive carcinomas of the lateral and anterior lobes
and of seminal vesicles and intra-acinar carcinomas in the dorsal prostate.
The appearance of carcinomas in the lateral and anterior prostate was incr
eased by co-administration of EE in a dose-related fashion but carcinomas o
f the seminal vesicles were inversely reduced. The suppressive influence of
TP on ventral carcinoma development was overcome by only the highest dose
of EE. It is concluded that estrogen can modify the enhancing effects of TP
on induction of rat prostate and seminal vesicle carcinomas in a dose-rela
ted fashion with lobe specificity. (C) 2000 Elsevier Science Ireland Ltd. A
ll rights reserved.